+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia-Pacific Advanced Wound Care Market Size, Share & Trends Analysis Report by Product (Moist, Antimicrobial), Application (Chronic Wounds), End-use (Hospitals, Specialty Clinics), Country, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 100 Pages
  • March 2024
  • Region: Asia Pacific
  • Grand View Research
  • ID: 5950081
The Asia Pacific advanced wound care market size is anticipated to reach USD 2.48 billion by 2030 and is projected to grow at a CAGR of 5.4% from 2024 to 2030. The rising incidence of chronic wounds is the major factor contributing to the market growth. For instance, in January 2023, MiMedx Group, Inc., a prominent player in placental biologics, secured an exclusive distribution partnership with Gunze Medical Limited, a subsidiary of Gunze Limited, to market EPIFIX exclusively in Japan.

Improvements in healthcare infrastructure and surgical accessibility drive demand for advanced wound care solutions, spurred by increasing surgical procedures and the prevalence of chronic diseases and age-related conditions. According to the United Nations ESCAP (Economic and Social Commission for Asia and the Pacific, by 2023, Asia and the Pacific were expected to have approximately 697 million individuals aged 60 years or older, constituting approximately 60% of the global older population, with one in every 7 individuals in the region falling into this age group. Projections indicated that by 2050, one in every 4 individuals in the region will be aged 60 years or older.

Moreover, the rising prevalence of chronic ailments such as diabetes, cancer, and autoimmune disorders is expected to elevate the occurrence of chronic wounds in the Asia Pacific region. According to the World Health Organization (WHO), within the WHO South-East Asia Region, diabetes affects over 96 million individuals, leading to significant economic burdens on patients, their families, healthcare systems, and national economies due to associated complications like blindness, kidney failure, heart attacks, strokes, and lower limb amputations.

Asia Pacific Advanced Wound Care Market Report Highlights

  • Based on product, the moist segment led the market with the largest revenue share of 70.9% in 2023, owing to increasing geriatric population in many Asian countries, coupled with rising incidences of chronic diseases such as diabetes, which has led to a higher prevalence of chronic injuries that require advanced wound care solutions. Also, the active segment is expected to grow at the fastest CAGR over the forecast period
  • Based on application, the chronic wounds segment held the market with the largest revenue share of 59.4% in 2023, owing to the technological advancements, encompassing a range of solutions, such as advanced injuries dressings, negative pressure wound therapy systems, bioactive wound care products, and topical oxygen therapy devices, among others. On other hand, the acute wounds segment is expected to grow at the fastest CAGR over the forecast period
  • Based on end-use, hospitals segment led the market with the largest revenue share of 45.4% in 2023, as chronic diseases and aging increase, hospitals face more patients needing advanced wound care, which boosts the demand for related products and treatments. The home healthcare segment is expected to grow at the fastest CAGR over the forecast period
  • In September 2023, Microsoft and healthcare technology company Paige collaborated to develop the most extensive image-based artificial intelligence (AI) models for digital pathology and oncology globally. This initiative seeks to revolutionize cancer diagnosis and enhance patient care. Leveraging advancements in the field, the partnership aspires to create a transformative impact on how cancer is diagnosed and treated, ultimately contributing to advancements in healthcare technology


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Asia Pacific Advanced Wound Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Asia Pacific Advanced Wound Care Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social Landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal Landscape
Chapter 4. Asia Pacific Advanced Wound Care Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Asia Pacific Advanced Wound Care Market, by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Moist
4.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.2. Foam Dressings
4.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.3. Hydrocolloid Dressings
4.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.4. Film Dressings
4.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.5. Alginate Dressings
4.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.6. Hydrogel Dressings
4.4.1.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.7. Collagen Dressings
4.4.1.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.8. Other Advanced Dressings
4.4.1.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Antimicrobial
4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.2. Silver
4.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.3. Non-Silver
4.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Active
4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3.2. Biomaterials
4.4.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3.3. Skin-substitute
4.4.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3.4. Growth factors
4.4.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Asia Pacific Advanced Wound Care Market: Application Estimates & Trend Analysis
5.1. Application Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Asia Pacific Wound Care Market, by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Chronic wounds
5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.1.2. Diabetic Foot Ulcers
5.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.1.3. Pressure Ulcers
5.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.1.4. Venous Leg Ulcers
5.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.1.5. Other Chronic Wounds
5.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2. Acute wounds
5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2.2. Surgical & Traumatic Wounds
5.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2.3. Burns
5.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Asia Pacific Advanced Wound Care Market: End-use Estimates & Trend Analysis
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Asia Pacific Advanced Wound Care Market, by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Hospitals
6.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD million)
6.4.2. Specialty clinics
6.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.3. Home healthcare
6.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.4. Others
6.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Asia Pacific Advanced Wound Care Market: Country Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. Asia Pacific
7.4.1. Japan
7.4.1.1. Key country dynamics
7.4.1.2. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. China
7.4.2.1. Key country dynamics
7.4.2.2. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.3. India
7.4.3.1. Key country dynamics
7.4.3.2. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.4. South Korea
7.4.4.1. Key country dynamics
7.4.4.2. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key country dynamics
7.4.5.2. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key country dynamics
7.4.6.2. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key companies heat map analysis, 2023
8.4. Company Profiles
8.4.1. Mölnlycke Health Care AB
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. 3M
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Smith & Nephew
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Baxter
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Cardinal Health
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Medline Industries, Inc.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. ConvaTec Inc.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. MIMEDX Group, Inc.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. L&R Group of Companies
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Johnson & Johnson Services, Inc.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. Integra LifeSciences Corporation
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. B. Braun SE
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
8.4.13. Coloplast Group
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Product benchmarking
8.4.13.4. Strategic initiatives
8.4.14. Hollister Incorporated
8.4.14.1. Company overview
8.4.14.2. Financial performance
8.4.14.3. Product benchmarking
8.4.14.4. Strategic initiatives
8.4.15. Zimmer Biomet
8.4.15.1. Company overview
8.4.15.2. Financial performance
8.4.15.3. Product benchmarking
8.4.15.4. Strategic initiatives
8.4.16. Medtronic
8.4.16.1. Company overview
8.4.16.2. Financial performance
8.4.16.3. Product benchmarking
8.4.16.4. Strategic initiatives
8.4.17. Elkem ASA
8.4.17.1. Company overview
8.4.17.2. Financial performance
8.4.17.3. Product benchmarking
8.4.17.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Asia Pacific advanced wound care market, by region, 2018 - 2030 (USD Million)
Table 3 Asia Pacific advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 4 Asia Pacific advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 5 Asia Pacific advanced wound care market, by end-use, 2018 - 2030 (USD Million)
Table 6 Japan advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 7 Japan advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 8 Japan advanced wound care market, by end-use, 2018 - 2030 (USD Million)
Table 9 China advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 10 China advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 11 China advanced wound care market, by end-use, 2018 - 2030 (USD Million)
Table 12 India advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 13 India advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 14 India advanced wound care market, by end-use, 2018 - 2030 (USD Million)
Table 15 South Korea advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 16 South Korea advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 17 South Korea advanced wound care market, by end-use, 2018 - 2030 (USD Million)
Table 18 Australia advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 19 Australia advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 20 Australia advanced wound care market, by end-use, 2018 - 2030 (USD Million)
Table 21 Thailand advanced wound care market, by product, 2018 - 2030 (USD Million)
Table 22 Thailand advanced wound care market, by application, 2018 - 2030 (USD Million)
Table 23 Thailand advanced wound care market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in APAC
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Asia Pacific advanced wound care market: market outlook
Fig. 10 Asia Pacific advanced wound care competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Asia Pacific advanced wound care market driver impact
Fig. 15 Asia Pacific advanced wound care market restraint impact
Fig. 16 Asia Pacific advanced wound care market: Product movement analysis
Fig. 17 Asia Pacific advanced wound care market: Product outlook and key takeaways
Fig. 18 Moist market estimates and forecast, 2018 - 2030
Fig. 19 Foam dressings market estimates and forecast, 2018 - 2030
Fig. 20 Hydrocolloid dressings market estimates and forecast, 2018 - 2030
Fig. 21 Film dressings market estimates and forecast, 2018 - 2030
Fig. 22 Alginate dressings market estimates and forecast, 2018 - 2030
Fig. 23 Hydrogel dressings market estimates and forecast, 2018 - 2030
Fig. 24 Collagen dressings market estimates and forecast, 2018 - 2030
Fig. 25 Other advanced dressings market estimates and forecast, 2018 - 2030
Fig. 26 Antimicrobial market estimates and forecast, 2018 - 2030
Fig. 27 Silver market estimates and forecast, 2018 - 2030
Fig. 28 Non-silver market estimates and forecast, 2018 - 2030
Fig. 29 Active market estimates and forecast, 2018 - 2030
Fig. 30 Biomaterials market estimates and forecast, 2018 - 2030
Fig. 31 Skin-substitute market estimates and forecast, 2018 - 2030
Fig. 32 Growth factors market estimates and forecast, 2018 - 2030
Fig. 33 Asia Pacific advanced wound care market: End-use movement Analysis
Fig. 34 Asia Pacific advanced wound care market: End-use outlook and key takeaways
Fig. 35 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 36 Specialty clinics market estimates and forecasts,2018 - 2030
Fig. 37 Home healthcare market estimates and forecasts,2018 - 2030
Fig. 38 Others market estimates and forecasts,2018 - 2030
Fig. 39 Asia Pacific advanced wound care market: Regional movement analysis
Fig. 40 Asia Pacific advanced wound care market: Regional outlook and key takeaways
Fig. 41 Asia Pacific advanced wound care market share and leading players
Fig. 42 Asia Pacific market share and leading players
Fig. 43 Asia Pacific SWOT
Fig. 44 Asia Pacific
Fig. 45 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 46 Japan
Fig. 47 Japan market estimates and forecasts, 2018 - 2030
Fig. 48 China
Fig. 49 China market estimates and forecasts, 2018 - 2030
Fig. 50 India
Fig. 51 India market estimates and forecasts, 2018 - 2030
Fig. 52 South Korea
Fig. 53 South Korea market estimates and forecasts, 2018 - 2030
Fig. 54 Australia
Fig. 55 Australia market estimates and forecasts, 2018 - 2030
Fig. 56 Thailand
Fig. 57 Thailand market estimates and forecasts, 2018 - 2030

Companies Mentioned

  • Mölnlycke Health Care AB
  • 3M
  • Smith & Nephew
  • Baxter
  • Cardinal Health
  • Medline Industries, Inc.
  • ConvaTec Inc.
  • MIMEDX Group, Inc.
  • L&R Group of Companies
  • Johnson & Johnson Services, Inc.
  • Integra LifeSciences Corporation
  • B. Braun SE
  • Coloplast Group
  • Hollister Incorporated
  • Zimmer Biomet
  • Medtronic
  • Elkem ASA

Methodology

Loading
LOADING...

Table Information